Abstract |
Eleven patients with uncomplicated mild-to-moderate hypertension (diastolic pressure 95-115 mmHg) were treated for four weeks with daily single quinapril doses of 20-40 mg. Already during the second week a significant reduction in blood pressure was observed without increase of heart rate; 27.3% of patients responded to the lower dose (diastolic blood pressure [90 mmHg], and 54.6% responded to the higher dose. Drug treatment led to reduced pressure increase in response to cold stimulation without influencing the adrenergic response both in basal conditions and after cold pressor test. The drug brought about peripheral vasodilatation as shown by increased perfusion index during Doppler ultrasound examination, and improved arterial reactivity with increased perfusion index and reduced recovery time after ischemia. The reduction of angiotensin and aldosterone plasma levels during treatment was not correlated to diminished blood pressure values, indicating that the antihypertensive effect can occur via pathways different from ACE inhibition. Tolerance was excellent as shown both by clinical and laboratory evidence.
|
Authors | A Saitta, M Bonaiuto, A Mileto, S Oriti, S Campo, G Giordano, M Cinquegrani, M N Saitta, P Fodale |
Journal | La Clinica terapeutica
(Clin Ter)
Vol. 134
Issue 5
Pg. 289-99
(Sep 15 1990)
ISSN: 0009-9074 [Print] Italy |
Vernacular Title | Valutazione clinico-strumentale degli effetti di un trattamento con quinapril nell'ipertensione lieve-moderata. |
PMID | 2149311
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Angiotensin-Converting Enzyme Inhibitors
- Antihypertensive Agents
- Isoquinolines
- Tetrahydroisoquinolines
- Quinapril
|
Topics |
- Angiotensin-Converting Enzyme Inhibitors
(pharmacology, therapeutic use)
- Antihypertensive Agents
(pharmacology, therapeutic use)
- Blood Pressure
(drug effects)
- Drug Evaluation
- Drug Tolerance
- Female
- Heart Rate
(drug effects)
- Humans
- Hypertension
(drug therapy)
- Isoquinolines
(pharmacology, therapeutic use)
- Male
- Middle Aged
- Quinapril
- Tetrahydroisoquinolines
|